Overview

  • Product nameIsradipine
  • Description
    L-type Ca2+ channel blocker
  • Biological descriptionL-type Ca2+ channel blocker.
  • Purity> 98%

Properties

    References for Isradipine (ab120142)

    This product has been referenced in:
    • Berjukow S  et al. Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem 275:22114-20 (2000). Read more (PubMed: 10766758) »
    • Zühlke RD  et al. Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human alpha1C subunit gene. FEBS Lett 427:220-4 (1998). Read more (PubMed: 9607315) »
    • Rüegg UT & Hof RP Pharmacology of the calcium antagonist isradipine. Drugs 40 Suppl 2:3-9 (1990). Read more (PubMed: 2150637) »

    See 0 Publications for this product

    Product Wall

    There are currently no Questions for ab120142.
    Please use the link above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"